Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
Pre-Tax Income
Meridian Bioscience Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Meridian Bioscience Inc
NASDAQ:VIVO
|
Pre-Tax Income
$54.3m
|
CAGR 3-Years
20%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Cooper Companies Inc
NYSE:COO
|
Pre-Tax Income
$410.8m
|
CAGR 3-Years
10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Pre-Tax Income
-$116m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
Align Technology Inc
NASDAQ:ALGN
|
Pre-Tax Income
$665m
|
CAGR 3-Years
4%
|
CAGR 5-Years
8%
|
CAGR 10-Years
14%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Pre-Tax Income
$593.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
See Also
What is Meridian Bioscience Inc's Pre-Tax Income?
Pre-Tax Income
54.3m
USD
Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Pre-Tax Income amounts to 54.3m USD.
What is Meridian Bioscience Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
8%
Over the last year, the Pre-Tax Income growth was -40%. The average annual Pre-Tax Income growth rates for Meridian Bioscience Inc have been 20% over the past three years , 8% over the past five years .